[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100512414":3},{"organization":4,"armGroups":7,"interventions":29,"overallOfficials":48,"centralContacts":55,"locations":64,"responsibleParty":105,"collaborators":108,"id":114,"slug":115,"hasResults":116,"nctId":117,"briefTitle":118,"officialTitle":119,"acronym":35,"eligibilityCriteria":120,"healthyVolunteers":116,"sex":121,"minAge":122,"maxAge":35,"enrollmentInfo":123,"targetDuration":35,"studyType":126,"phases":127,"briefSummary":129,"conditions":130,"keywords":132,"overallStatus":80,"whyStopped":35,"lastUpdateSubmitDate":136,"lastUpdatePostDateStruct":137,"startDateStruct":140,"completionDateStruct":142,"leadSponsor":144,"locationsCount":145},{"fullName":5,"class":6},"Abramson Cancer Center at Penn Medicine","OTHER",[8,15,20,25],{"label":9,"type":10,"description":11,"interventionNames":12},"Stage 1 Clinic Outreach + Stage 2 Low Touch","EXPERIMENTAL","All participants receive direct clinic outreach to communicate readiness of results (stage 1). Participants who do not attend the clinic by 30 days (non-responders) will receive asynchronous text message reminders using framed messaging (stage 2).",[13,14],"Behavioral: Clinic Outreach","Behavioral: Low-Touch Strategy",{"label":16,"type":10,"description":17,"interventionNames":18},"Stage 1 Clinic Outreach + Stage 2 High Touch","All participants receive direct clinic outreach to communicate readiness of results (stage 1). Participants who do not attend the clinic by 30 days (non-responders) will receive asynchronous text message reminders using framed messaging in combination with synchronous patient navigation (stage 2).",[13,19],"Behavioral: High-Touch Strategy",{"label":21,"type":10,"description":22,"interventionNames":23},"Stage 1 Enhanced Outreach + Stage 2 Low-Touch","All participants receive direct clinic outreach plus enhanced outreach to communicate readiness of results (stage 1). Participants who do not attend the clinic by 30 days (non-responders) will receive asynchronous text message reminders using framed messaging (stage 2).",[24,14],"Behavioral: Enhanced Outreach",{"label":26,"type":10,"description":27,"interventionNames":28},"Stage 1 Enhanced Outreach + Stage 2 High-Touch","All participants receive direct clinic outreach plus enhanced outreach to communicate readiness of results (stage 1). Participants who do not attend the clinic by 30 days (non-responders) will receive asynchronous text message reminders using framed messaging in combination with synchronous patient navigation.",[24,19],[30,36,40,44],{"type":31,"name":32,"description":33,"armGroupLabels":34,"otherNames":35},"BEHAVIORAL","Clinic Outreach","A member of the pathology team will contact the referring clinic to communicate the readiness of results.",[16,9],null,{"type":31,"name":37,"description":38,"armGroupLabels":39,"otherNames":35},"Enhanced Outreach","A member of the pathology team will contact both the referring clinic and the patient directly to communicate the readiness of results.",[26,21],{"type":31,"name":41,"description":42,"armGroupLabels":43,"otherNames":35},"Low-Touch Strategy","Patient will be sent asynchronous text messaging reminders related to the importance of timely care using framed messaging.",[9,21],{"type":31,"name":45,"description":46,"armGroupLabels":47,"otherNames":35},"High-Touch Strategy","Patient will be sent asynchronous text messaging reminders related to the importance of timely care using framed messaging in combination with synchronous telephone-based patient navigation.",[16,26],[49,53],{"name":50,"affiliation":51,"role":52},"Katharine Rendle, PhD,MSW,MPH","University of Pennsylvania","PRINCIPAL_INVESTIGATOR",{"name":54,"affiliation":51,"role":52},"Surbhi Grover, MD, MPH",[56,60],{"name":50,"role":57,"phone":58,"phoneExt":35,"email":59},"CONTACT","215-349- 5442","katharine.rendle@pennmedicine.upenn.edu",{"name":61,"role":57,"phone":62,"phoneExt":35,"email":63},"Hannah Toneff, MSW, MA","267-882-3186","hannah.toneff@pennmedicine.upenn.edu",[65,78,93],{"facility":51,"status":66,"city":67,"state":68,"zip":69,"country":70,"countryCode":71,"cosmosGeoPoint":72,"geoPoint":77,"contacts":35},"ACTIVE_NOT_RECRUITING","Philadelphia","Pennsylvania","19104","United States","US",{"type":73,"coordinates":74},"Point",[75,76],-75.16362,39.95238,{"lat":76,"lon":75},{"facility":79,"status":80,"city":81,"state":82,"zip":35,"country":83,"countryCode":84,"cosmosGeoPoint":35,"geoPoint":35,"contacts":85},"Nyangabgwe Referral Hospital","RECRUITING","Francistown","North-East District","Botswana","BW",[86,90],{"name":87,"role":57,"phone":88,"phoneExt":35,"email":89},"Surbhi Grover, MD","2672076977","surbhi.grover@pennmedicine.upenn.edu",{"name":91,"role":57,"phone":35,"phoneExt":35,"email":92},"Irene Ramokate","ramokatei@bup.org.bw",{"facility":94,"status":80,"city":95,"state":35,"zip":35,"country":83,"countryCode":84,"cosmosGeoPoint":96,"geoPoint":100,"contacts":101},"Princess Marina Hospital","Gaborone",{"type":73,"coordinates":97},[98,99],25.90859,-24.65451,{"lat":99,"lon":98},[102,104],{"name":54,"role":57,"phone":35,"phoneExt":35,"email":103},"Surbhi.Grover@pennmedicine.upenn.edu",{"name":54,"role":52,"phone":35,"phoneExt":35,"email":35},{"type":52,"investigatorFullName":106,"investigatorTitle":107,"investigatorAffiliation":5,"oldNameTitle":35,"oldOrganization":35},"Katharine Rendle","Principal Investigator",[109,112],{"name":110,"class":111},"National Cancer Institute (NCI)","NIH",{"name":113,"class":6},"University of Botswana","100512414","strategies-to-close-the-gap-from-cervical-cancer-diagnosis-to-treatment-in-botswana-100512414",false,"NCT05952141","Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana","Thibang Diphatlha: Testing Adaptive Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana","Inclusion Criteria:\n\nPatients will be eligible if they:\n\n1. are biological females\n2. are aged 18 or older\n3. have pathology-confirmed invasive cervical cancer diagnosis\n4. have pathology results evaluated at National Health Laboratory in Botswana\n5. are citizens of Botswana\n6. have no prior history of invasive cervical cancer\n\nExclusion Criteria:\n\nPatients will be excluded if they:\n\n1. are biological males or otherwise born without a cervix\n2. are below the age of 18 due to the rarity of cervical cancer in this population\n3. do not meet study inclusion criteria","FEMALE","18 Years",{"count":124,"type":125},610,"ESTIMATED","INTERVENTIONAL",[128],"NA","Investigators will test the effectiveness of adaptive strategies on timely adoption of cervical cancer treatment in Botswana using a pragmatic trial design.",[131],"Cervical Cancer",[133,83,134,135],"Screening","Treatment","Patient","2026-07-21",{"date":138,"type":139},"2026-07-22","ACTUAL",{"date":141,"type":139},"2023-09-01",{"date":143,"type":125},"2027-08-31",{"name":5,"class":6},3]